Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Verrica Pharmaceuticals Ownership Summary


Verrica Pharmaceuticals is owned by 26.03% institutional investors, 43.45% insiders, and 30.52% retail investors. Caligan partners lp is the largest institutional shareholder, holding 17.36% of VRCA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.37% of its assets in Verrica Pharmaceuticals shares.

VRCA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVerrica Pharmaceuticals26.03%43.45%30.52%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Caligan partners lp8.99M17.36%$3.98M
Armistice capital8.88M9.36%$4.71M
Vanguard group1.88M4.02%$1.32M
Blackrock1.13M2.43%$8.23M
Geode capital management477.27K1.02%$334.13K
State street451.78K0.97%$3.29M
Millennium management395.65K0.76%$174.96K
Renaissance233.30K0.50%$163.31K
Northern trust190.68K0.41%$1.39M
Ubs group174.06K0.37%$121.84K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp8.99M0.83%$3.98M
Armistice capital8.88M0.08%$4.71M
Bml capital management174.65K0.07%$92.58K
Y-intercept (hong kong)186.96K0.00%$99.11K
Spc financial30.00K0.00%$21.00K
Steel peak wealth management76.00K0.00%$40.29K
Dynamic technology lab private20.30K0.00%$11.00K
Point72 asia (singapore) pte.13.72K0.00%$7.27K
Miracle mile advisors84.00K0.00%$58.80K
Key financial9.41K0.00%$4.99K

Top Buyers

HolderShares% AssetsChange
Caligan partners lp8.99M0.83%1.56M
Vanguard group1.88M-593.31K
Millennium management395.65K0.00%395.65K
Armistice capital8.88M0.08%313.94K
Y-intercept (hong kong)186.96K0.00%186.96K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---4.00M
Perceptive advisors---3.25M
Boothbay fund management---2.81M
Blackrock funding, inc. /de56.47K--1.17M
Fmr14.67K--619.64K

New Positions

HolderShares% AssetsChangeValue
Y-intercept (hong kong)186.96K0.00%186.96K$99.11K
Dynamic technology lab private20.30K0.00%20.30K$11.00K
Aqr capital management14.44K-14.44K$10.11K
Point72 asia (singapore) pte.13.72K0.00%13.72K$7.27K
Raymond james financial8.40K-8.40K$4.45K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
True wealth design-8.00
Sterling capital management-19.00
Mai capital management-21.00
Farther finance advisors-31.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202552-27.78%24,696,020-16.20%262.70%23-41.03%20100.00%
Mar 31, 20253-96.25%9,407,623-68.57%180.44%2-95.12%--100.00%
Dec 31, 202477-3.75%29,394,92197.36%626.20%39-9.30%1812.50%
Sep 30, 2024795.33%14,834,226-20.43%311.97%427.69%16-
Jun 30, 20247421.31%18,643,9415.04%402.62%38111.11%16-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv127.02K1.37%-2.78K
Invesco Dorsey Wright SmallCap Momt ETF409.00K0.96%-
Vanguard US Total Market Shares ETF815.89K0.89%-
Vanguard Institutional Extnd Mkt Idx Tr65.21K0.71%-15.05K
Fidelity Select Biotechnology517.63K0.57%-112.24K
iShares Russell 2000 ETF520.96K0.56%-
Simplify Propel Opportunities ETF200.00K0.44%-
Fidelity Small Cap Index385.38K0.42%-
DWS Small Cap Core S174.70K0.41%-
Small Cap Core Equity Composite174.70K0.41%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2025Hayes Christopher G. CHIEF LEGAL OFFICERSell$2.80K
Nov 22, 2024Rieger Jayson CEO and PresidentBuy$187.50K
Nov 22, 2024Rieger Jayson CEO and PresidentBuy$150.00K
Nov 22, 2024Rieger Jayson CEO and PresidentBuy$250.00K
Nov 22, 2024Stalfort John A III-Buy$1000.00K

Insider Transactions Trends


DateBuySell
2025 Q1-1
2024 Q412-
2024 Q3-18
2024 Q2--
2024 Q1--

VRCA Ownership FAQ


Who Owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals shareholders are primarily institutional investors at 26.03%, followed by 43.45% insiders and 30.52% retail investors. The average institutional ownership in Verrica Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Verrica Pharmaceuticals falls below.

Who owns the most shares of Verrica Pharmaceuticals?

Verrica Pharmaceuticals’s largest shareholders are Caligan partners lp (8.99M shares, 17.36%), Armistice capital (8.88M shares, 9.36%), and Vanguard group (1.88M shares, 4.02%). Together, they hold 30.74% of Verrica Pharmaceuticals’s total shares outstanding.

Does Blackrock own Verrica Pharmaceuticals?

Yes, BlackRock owns 2.43% of Verrica Pharmaceuticals, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.23M$. In the last quarter, BlackRock increased its holdings by 15.08K shares, a 1.35% change.

Who is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.83% of its assets in 8.99M Verrica Pharmaceuticals shares, valued at 3.98M$.

Who is the top mutual fund holder of Verrica Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Verrica Pharmaceuticals shares, with 1.37% of its total shares outstanding invested in 127.02K Verrica Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools